Gary J. Beeman Appointed CEO Of GeneLink BioSciences, Inc.
ORLANDO, Fla., Feb. 18 /PRNewswire-FirstCall/ -- GeneLink BioSciences, Inc. (OTC Bulletin Board: GNLK), a leading consumer genomics, wellness, and biotechnology company ( www.genelinkbio.com), is pleased to announce the appointment of Gary J. Beeman as its Chief Executive Officer and President, effective February 17, 2010.
Mr. Beeman is a seasoned public and private company CEO and entrepreneur, with a proven record of achieving fast growth and profitability for early stage technology companies. Mr. Beeman brings over 30 years of experience in senior management positions growing and operating leading edge global marketing and manufacturing companies. Prior to joining GeneLink, Mr. Beeman most recently served as CEO and a founder of Bay Hill Ventures, a private capital firm. Mr. Beeman has also served as Strategic Planning advisor to the GeneLink Board of Directors and as Director of Marketing Communications for GeneWize Life Sciences, Inc. during the past two years. Mr. Beeman succeeds David L. Macdonald, GeneLink's interim CEO, who will continue to work with GeneLink in a consulting capacity.
"I'm excited and honored to lead the GeneLink team into its next major growth and profitability phase," said Gary Beeman, Chief Executive Officer, GeneLink BioSciences. "With the untenable crisis in healthcare costs paving the way, wellness has finally become the economic driver that it always should have been- simply because sickness is no longer affordable. GeneLink's 16 years of genomic and nutraceutical research and product development has perfectly positioned us to lead the new era of Genetically-guided Personalized Wellness products. GeneLink is a true game-changer, and a business model that is sustainable for the long term. "
GeneWize Life Sciences, Inc. ( www.genewize.com), GeneLink's direct marketing subsidiary, is also pleased to announce that Sharon M. Tahaney has been named President of GeneWize, effective February 17, 2010. Ms. Tahaney had previously been the Senior Vice President of Sales and Marketing for GeneWize. In less than a year, Ms. Tahaney has developed and implemented the GeneWize Strategic Growth Plan including a brand lift, new pricing strategies, new marketing tools, and has taken over as the leader and face of GeneWize and its valued Affiliates."I am privileged to lead such an extraordinary team of Affiliates at GeneWize Life Sciences," said Ms. Tahaney. "We are on a mission that's bigger than any one of us and requires all of us. We connect the latest in biotechnology and genetic testing to custom-blend nutrition and skin care."
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV